GB2148841A — Capsulated medicaments
Assigned to Warner Lambert Co LLC · Expires 1985-06-05 · 41y expired
What this patent protects
A divisible hard shell capsule in dosage form, has a plurality of connected subunits each comprising a joined or joinable cap part (2) and body part (1), wherein the body parts (1) are joined by connection elements (5) and/or cap parts (2) are joined by connection elements (5), t…
USPTO Abstract
A divisible hard shell capsule in dosage form, has a plurality of connected subunits each comprising a joined or joinable cap part (2) and body part (1), wherein the body parts (1) are joined by connection elements (5) and/or cap parts (2) are joined by connection elements (5), the connection elements (5) being integrally moulded with the body parts (1) and/or the cap parts (2), and the connection elements (5) being breakable whereby the capsule may be divided into subunits. A compartmented hard shell capsule in dosage form, comprises a joined or joinable cap part (2) and body part (1), wherein the body part (1) has one or more internal partitions integrally moulded therein so as to form two or more compartments intended for medicaments within the body (1) and the cap (2), when joined, for pharmaceutical dosage. <IMAGE>
Drugs covered by this patent
- Remodulin (TREPROSTINIL) · United Therap
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.